- Home
- EU vs IVVD Comparison
EU vs IVVD Comparison
Compare EU & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EU | IVVD |
|---|---|---|
| Founded | 2009 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 464.5M | 437.1M |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EU | IVVD |
|---|---|---|
| Price | $2.22 | $1.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $4.00 | ★ $8.75 |
| AVG Volume (30 Days) | ★ 3.0M | 2.1M |
| Earning Date | 01-01-0001 | 04-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.99 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $58,334,000.00 | $25,384,000.00 |
| Revenue This Year | $17.41 | $107.86 |
| Revenue Next Year | $95.45 | $146.53 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 163.38 | N/A |
| 52 Week Low | $1.01 | $0.46 |
| 52 Week High | $4.19 | $3.07 |
Technical Indicators
Market Signals| Indicator | EU | IVVD |
|---|---|---|
| Relative Strength Index (RSI) | 32.43 | 44.01 |
| Support Level | $1.54 | $1.41 |
| Resistance Level | $2.56 | $2.01 |
| Average True Range (ATR) | 0.19 | 0.10 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 9.62 | 64.81 |
Price Performance
Historical ComparisonAbout EU enCore Energy Corp.
enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties of uranium resource properties in the United States. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's Projects are South Texas Operations, Dewey-Burdock Project, Gas Hills Project, Crownpoint & Hosta Butte Project, PFN (Prompt Fission Neutron) Technology, and Other Assets.
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.